- Home
- / e-therapeutics
e-therapeutics
Total Funding
$66.8 M
e-therapeutics Summary
Company Summary
- Overview
- e-therapeutics is a computational drug discovery company. It develops a platform that incorporates big data, as well as AI and machine learning. Its solution helps the company discover drugs.
- Type
- Private
- Status
- Active
- Founded
- 2003
- HQ
- Long Hanborough, GB | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Ali Mortazavi, Chief Executive Officer and Director
Laura Roca-Alonso, Chief Operating and Business Officer
Alison Gallafent, Chief Intellectual Property Officer
Operating MetricsView all
Projects Launched
12
100.0%
FY, 2016
LocationsView all
2 locations detected
Long Hanborough, England HQ
United Kingdom
Blenheim Office Park, 17 Fenlock Rd
Newcastle upon Tyne, England
United Kingdom
11 Waterloo St
e-therapeutics Financials
Summary Financials
- Net income (FY, 2025)
- (£14.9M)
- Cash (FY, 2025)
- £20.5M
- EBIT (FY, 2025)
- (£18.6M)